These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26973199)

  • 41. Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.
    Yeh YC; Nitadori J; Kadota K; Yoshizawa A; Rekhtman N; Moreira AL; Sima CS; Rusch VW; Adusumilli PS; Travis WD
    Histopathology; 2015 Jun; 66(7):922-38. PubMed ID: 24889415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.
    Ujiie H; Kadota K; Chaft JE; Buitrago D; Sima CS; Lee MC; Huang J; Travis WD; Rizk NP; Rudin CM; Jones DR; Adusumilli PS
    J Clin Oncol; 2015 Sep; 33(26):2877-84. PubMed ID: 26261257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristic immunophenotype of solid subtype component in lung adenocarcinoma.
    Takuwa T; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Neri S; Hasegawa S; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3943-52. PubMed ID: 22669454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications.
    Lee HJ; Lee CH; Jeong YJ; Chung DH; Goo JM; Park CM; Austin JH
    J Thorac Imaging; 2012 Nov; 27(6):340-53. PubMed ID: 23086014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma.
    Suzuki M; Matsumoto Y; Imabayashi T; Teishikata T; Tsuchida T; Asamura H; Yatabe Y
    Lung Cancer; 2021 Dec; 162():147-153. PubMed ID: 34814012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis.
    Jiang L; Mino-Kenudson M; Roden AC; Rosell R; Molina MÁ; Flores RM; Pilz LR; Brunelli A; Venuta F; He J;
    Eur J Surg Oncol; 2019 May; 45(5):870-876. PubMed ID: 30833014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
    Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.
    Aokage K; Ishii G; Yoshida J; Hishida T; Nishimura M; Nagai K; Ochiai A
    Pathol Int; 2010 Dec; 60(12):765-73. PubMed ID: 21091834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
    Travis WD; Brambilla E; Riely GJ
    J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection.
    Casteillo F; Guy JB; Dal-Col P; Karpathiou G; Pommier B; Bayle-Bleuez S; Fournel P; Vassal F; Forest F
    Am J Surg Pathol; 2018 Dec; 42(12):1701-1707. PubMed ID: 30222604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Clin Lung Cancer; 2015 May; 16(3):209-15. PubMed ID: 25467929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact.
    Sterlacci W; Savic S; Schmid T; Oberaigner W; Auberger J; Fiegl M; Tzankov A
    Am J Clin Pathol; 2012 Jun; 137(6):946-56. PubMed ID: 22586054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.